EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial (NCT03694210) | Clinical Trial Compass
CompletedNot Applicable
EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial
United States30 participantsStarted 2018-11-15
Plain-language summary
A prospective, single arm, open label, multi-center, trial to evaluate the safety and effectiveness of the Interscope EndoRotor® Resection System in subjects requiring direct endoscopic necrosectomy (DEN) with walled off pancreatic necrosis (WOPN).
Who can participate
Age range22 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Subjects who are \>22; inclusive of males and females.
✓. Patients with symptomatic pancreatic necrosis due to acute pancreatitis that have an indication to undergo endoscopic necrosectomy after having undergone EUS-guided drainage
✓. Imaging suggestive of greater than or equal to 30% necrotic material
✓. Walled off pancreatic necrosis size ≥6 cm and ≤22cm
✓. Subject can tolerate repeated endoscopic procedures
✓. Subject capable of giving informed consent.
✓. Subjects with the ability to understand the requirements of the study, who have provided written informed consent, and who are willing and able to return for the required follow-up assessments through 21 (+/- 7) days, as indicated.
Exclusion criteria
✕. Subject unable to give informed consent.
✕. Subject is unwilling to return for repeated endoscopies.
✕. Documented Pseudoaneurysm \> 1cm within the WOPN
✕. Intervening gastric varices or unavoidable blood vessels within the access tract (visible using endoscopy or endoscopic ultrasound).
✕. Dual antiplatelet therapy or therapeutic anticoagulation that cannot be withheld for the procedure
What they're measuring
1
Safety: Number of Participants With Device Related Complications
. Any condition that in the opinion of the investigator would create an unsafe clinical situation that would not allow the patient to safely undergo an endoscopic procedure (lack of medical clearance).
✕. Pregnant or lactating women or women of childbearing potential who do not employ a reliable method of contraception as judged by the Investigator, and/or are not willing to use reliable contraception for the duration of study participation.
✕. Patient is known to be currently enrolled in another investigational trial that could interfere with the endpoint analyses of this trial.